CA Stock MarketDetailed Quotes

MDP Medexus Pharmaceuticals Inc

Watchlist
  • 3.090
  • -0.050-1.59%
15min DelayMarket Closed Feb 14 16:00 ET
99.68MMarket Cap14.31P/E (TTM)

Medexus Pharmaceuticals Inc Key Stats

Medexus Pharmaceuticals Inc Q3 2025 Earnings Date

Currency:CADFeb 5, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
40.84M
43.05M
+2.21M
Beat Est.
+20.27%
+28.81%
+5.42%
EPS
0.06
0.04
-0.02
Miss Est.
+325.37%
+262.42%
-28.64%

Medexus Pharmaceuticals Inc Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CAD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2026/Q1-- / 33.408M--
--2025/Q4-- / 35.972M--
Feb 5, 20252025/Q342.853M / 40.835M--
Nov 7, 20242025/Q236.492M / 35.625M--
Aug 7, 20242025/Q137.455M / 36.666M--
DatePeriodRevenue/EstimateEarnings Call
--2026/Q1-- / 33.408M--
--2025/Q4-- / 35.972M--
Feb 5, 20252025/Q342.853M / 40.835M--
Nov 7, 20242025/Q236.492M / 35.625M--
Aug 7, 20242025/Q137.455M / 36.666M--

Unlock Free Earnings Estimates

Medexus Pharmaceuticals Inc Earnings Reports

Read more

Trending Stocks
Dividend Kings of Canada Dividend Kings of Canada

Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility. Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility.